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Résumé en
anglais
Background Atrial fibrillation developing at the acute stage of myocardial infarction
is associated with untoward clinical outcomes. The aim of this study was to
determine correlations between early statin therapy and atrial fibrillation in acute
myocardial infarction.Methods Patients (3396) with sinus rhythm developing acute
myocardial infarction were enrolled in the French registry of Acute ST-elevation and
non-ST-elevation Myocardial Infarction (FAST-MI). Results Atrial fibrillation
developed in 7.0% of patients without and 3.9% of patients with early (≤48 h of
admission) statin therapy (p<0.001). Multivariable analysis, including the
propensity score for early statin treatment, showed that statin therapy was
associated with reduced risk of atrial fibrillation (OR 0.64; 95% CI 0.45 to 0.92,
p=0.017). Compared to patients without early statin therapy, the OR for atrial
fibrillation were 0.72 (0.49 to 1.04, p=0.080), 0.52 (0.28 to 0.95, p=0.034) and 0.40
(0.18 to 0.92, p=0.030) in patients on conventional, intermediate and high doses
respectively. Conclusions This study is the first to document a correlation between
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